Jordi M Argilaguet
Overview
Explore the profile of Jordi M Argilaguet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Argilaguet J, Perez-Martin E, Lopez S, Goethe M, Escribano J, Giesow K, et al.
Antiviral Res
. 2013 Feb;
98(1):61-5.
PMID: 23428670
Lack of vaccines and efficient control measures complicate the control and eradication of African swine fever (ASF). Limitations of conventional inactivated and attenuated virus-based vaccines against African swine fever virus...
2.
Galindo-Cardiel I, Ballester M, Solanes D, Nofrarias M, Lopez-Soria S, Argilaguet J, et al.
Virus Res
. 2013 Jan;
173(1):180-90.
PMID: 23313935
African swine fever is still one of the major viral diseases of swine for which a commercial vaccine is lacking. For the design and development of such preventive products, researchers...
3.
Takamatsu H, Denyer M, Lacasta A, Stirling C, Argilaguet J, Netherton C, et al.
Virus Res
. 2012 Dec;
173(1):110-21.
PMID: 23201582
African swine fever virus (ASFV) infection usually results in an acute haemorrhagic disease with a mortality rate approaching 100% in domestic pigs. However, pigs can survive infection with less-virulent isolates...
4.
Argilaguet J, Perez-Martin E, Nofrarias M, Gallardo C, Accensi F, Lacasta A, et al.
PLoS One
. 2012 Oct;
7(9):e40942.
PMID: 23049728
The lack of available vaccines against African swine fever virus (ASFV) means that the evaluation of new immunization strategies is required. Here we show that fusion of the extracellular domain...
5.
Vergara-Alert J, Argilaguet J, Busquets N, Ballester M, Martin-Valls G, Rivas R, et al.
PLoS One
. 2012 Jul;
7(7):e40524.
PMID: 22815759
Outbreaks involving either H5N1 or H1N1 influenza viruses (IV) have recently become an increasing threat to cause potential pandemics. Pigs have an important role in this aspect. As reflected in...
6.
Borrego B, Argilaguet J, Perez-Martin E, Dominguez J, Perez-Filgueira M, Escribano J, et al.
Antiviral Res
. 2011 Aug;
92(2):359-63.
PMID: 21820470
Development of efficient and safer vaccines against foot-and-mouth disease virus (FMDV) is a must. Previous results obtained in our laboratory have demonstrated that DNA vaccines encoding B and T cell...
7.
King K, Chapman D, Argilaguet J, Fishbourne E, Hutet E, Cariolet R, et al.
Vaccine
. 2011 May;
29(28):4593-600.
PMID: 21549789
African swine fever (ASF) is an acute haemorrhagic disease of domestic pigs for which there is currently no vaccine. We showed that experimental immunisation of pigs with the non-virulent OURT88/3...
8.
Perez-Martin E, Gomez-Sebastian S, Argilaguet J, Sibila M, Fort M, Nofrarias M, et al.
Vaccine
. 2010 Jan;
28(11):2340-9.
PMID: 20056179
Porcine circovirus type 2 (PCV2) vaccination has been recently included as a measure to control postweaning multisystemic wasting syndrome (PMWS) in the field. Aiming to obtain a more affordable vaccine...
9.
Perez-Martin E, Grau-Roma L, Argilaguet J, Nofrarias M, Escribano J, Gomez-Sebastian S, et al.
J Virol Methods
. 2008 Sep;
154(1-2):167-74.
PMID: 18773923
The main aim of the present study was to describe new methods for the identification of antibodies against the PCV2 capsid (Cap) and replicase (Rep) proteins in pig sera. Specifically,...